Announcements Trials
Browse Landscape

Phase

Phase 1 7Phase 1/2 4Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 11NIH 2INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2Sarcoma 1Dermatologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1Neoplasms 1Melanoma 1Head and Neck Neoplasms 1

Interventions

Carboplatin 272Paclitaxel 267Gemcitabine 244Bevacizumab 225Cisplatin 216pembrolizumab 213Docetaxel 210Pemetrexed 162Capecitabine 148Fluorouracil 129Oxaliplatin 121Cyclophosphamide 121Nivolumab 112Dexamethasone 99Trastuzumab 89Leucovorin 87Cetuximab 85Rituximab 83Irinotecan 82Injections 80Erlotinib Hydrochloride 70Prednisone 68Doxorubicin 68Temozolomide 67atezolizumab 65Ipilimumab 64Bortezomib 64Fulvestrant 59Radiotherapy 54Drug Therapy 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × INDUSTRY × poly ICLC × Clear all
NCT02873819 2022-03-08

Safety and Efficacy Study of GL-0817 (With Cyclophosphamide) for the Prevention of Recurrence of Squamous Cell Carcinoma of the Oral Cavity

Gliknik Inc.

Phase 2 Completed
80 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT02423863 2020-12-17

Poly-ICLC

Oncovir, Inc.

Phase 2 Completed
26 enrolled
DermatologicHead & NeckSarcoma

Head and Neck Neoplasms, Melanoma, Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡